|
MED23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.129000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.001800E-01 |
| Normal-vs-Stage2 |
8.416800E-01 |
| Normal-vs-Stage3 |
2.081600E-01 |
| Normal-vs-Stage4 |
1.631770E-01 |
| Stage1-vs-Stage2 |
9.509400E-01 |
| Stage1-vs-Stage3 |
3.716200E-01 |
| Stage1-vs-Stage4 |
3.075400E-01 |
| Stage2-vs-Stage3 |
6.057400E-01 |
| Stage2-vs-Stage4 |
5.231600E-01 |
| Stage3-vs-Stage4 |
8.284600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.207200E-01 |
| Normal-vs-AfricanAmerican |
8.618600E-01 |
| Normal-vs-Asian |
4.846400E-02 |
| Caucasian-vs-AfricanAmerican |
4.150400E-01 |
| Caucasian-vs-Asian |
8.895600E-02 |
| AfricanAmerican-vs-Asian |
6.941600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.080600E-01 |
| Normal-vs-Female |
7.431800E-01 |
| Male-vs-Female |
2.845800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.341210E-01 |
| Normal-vs-Age(41-60Yrs) |
9.830000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.572810E-01 |
| Normal-vs-Age(81-100Yrs) |
6.784200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.534000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.248000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.877800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.312590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.693820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.368600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.341920E-02 |
| Normal-vs-Grade 2 |
4.708000E-01 |
| Normal-vs-Grade 3 |
6.813800E-02 |
| Normal-vs-Grade 4 |
2.962100E-04 |
| Grade 1-vs-Grade 2 |
3.586200E-02 |
| Grade 1-vs-Grade 3 |
1.461550E-03 |
| Grade 1-vs-Grade 4 |
4.07639999999709E-05 |
| Grade 2-vs-Grade 3 |
4.619400E-03 |
| Grade 2-vs-Grade 4 |
1.6727299999908E-05 |
| Grade 3-vs-Grade 4 |
1.474240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.762830E-01 |
| Normal-vs-ccB subtype |
8.801300E-03 |
| ccA subtype-vs-ccB subtype |
3.77820000000417E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.701800E-01 |
| Normal-vs-N1 |
2.728500E-02 |
| N0-vs-N1 |
1.112220E-01 |
|
|
